Clinical Trials
5 trialsNCT04130854 2026-05-06
INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer
University of Texas Southwestern Medical Center
Phase 2 Completed
NCT03719430 2025-04-29
APX005M and Doxorubicin in Advanced Sarcoma
Columbia University
Phase 2 Active not recruiting
NCT03165994 2024-05-02
APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers
Apexigen America, Inc.
Phase 2 Completed
NCT04337931 2024-02-13
A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma
Apexigen America, Inc.
Phase 2 Terminated
NCT05201001 2023-09-11
APX005M
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Phase 2 Withdrawn